RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders

NCT05704582 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-02-07

No results posted yet for this study

Summary

The goal of this clinical trial is to conduct a single-blind randomized controlled trial to verify whether the Avatar Intervention has greater efficacy over supportive intervention to reduce cannabis use in patients with psychotic disorders.

Conditions

  • Psychotic Disorders
  • Cannabis Use Disorder
  • Mental Health Disorder

Interventions

OTHER

Avatar Intervention

8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.

OTHER

Addiction supportive intervention

8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Ciusss de L'Est de l'Île de Montréal

    lead OTHER

Principal Investigators

  • Alexandre Dumais, MD, PhD · University of Montreal, Institut universitaire en santé mentale de Montréal

  • Stephane Potvin, PhD · University of Montreal, Institut universitaire en santé mentale de Montréal

  • Emmanuel Stip, MD, MSc · United Arab Emirates University

  • Amal Abdel Baki, MD, MSc · University of Montreal, Centre hospitalier de l'Université de Montréal

  • Robert-Paul Juster, PhD · University of Montreal, Institut universitaire en santé mentale de Montréal

  • Marie-Hélène Goulet, PhD · University of Montreal, Institut universitaire en santé mentale de Montréal

  • Luigi De Benedictis, MD · Institut universitaire en santé mentale de Montréal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2027-01-31
Completion
2028-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05704582 on ClinicalTrials.gov